Bhuminathan Swamikannu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bhuminathan Swamikannu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Prabhu Manickam Natarajan
Department of Clinical Sciences, Centre of Medical and Bio-Allied Health Sciences and Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates
11 shared publications - Vidhya Rekha Umapathy
Department of Public Health Dentistry, Thai Moogambigai Dental College and Hospital, Dr. M.G.R. Educational and Research Institute, Chennai 600107, Tamil Nadu, India
10 shared publications Bindu Kamaraj
Department of Prosthodontics and Crown and Bridge, Vinayaka Mission’s Sankarachariyar Dental College, Vinayaka Mission’s Research Foundation (Deemed to be University), Tamil Nadu, India
2 shared publications- Chella Perumal Palanisamy
Phytochemistry and Pharmacotherapy Lab, Department of Dermatology, Saveetha Medical College & Hospital (SMCH), Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai, Tamil Nadu 602105, India
2 shared publications - Jinjin Pei
College of Food Science and Technology, Guangdong Provincial Key Laboratory of Aquatic Product Pro-cessing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guang-dong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, Guangdong Ocean University, Zhanjiang, 524088, China
2 shared publications Loganathan Kamaraj
Department of Oral and Maxillofacial Surgery, School of Allied Health Sciences, VMKVMC, Vinayaka Mission’s Research Foundation (Deemed to be University), Tamil Nadu, India
2 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- p. S18-S25
Automation and Robotics in Biosensing for Early Diagnosis and Monitoring of Peri-Implantitis – A Systematic Review.
Background Peri-implantitis is a progressive inflammatory illness that affects implant longevity. Early detection and continuous monitoring are crucial for efficient management. Recent breakthroughs in biosensing, automation, and robotics offer exciting prospects. The purpose of this systematic review is to assess the effectiveness of automation and robotic-assisted biosensing technologies in the early detection and real-time monitoring of peri-implantitis. Methods A complete search of PubMed, Scopus, Cochrane Library, IEEE Xplore, and Web of Science (2013- 2024) was carried out. Studies that used biosensors with automated or robotic systems to diagnose periimplantitis were considered. Methodological quality was evaluated using the PRISMA and ROBIS methods. Results 34 out of 562 articles met the requirements. Biosensing platforms (optical, electrochemical, piezoelectric) with AI integration demonstrated great sensitivity (80-95%) and specificity (85-98%) in detecting early biomarkers such as IL-1β, TNF-α, and MMPs. Robotic systems improved reproducibility and patient comfort. Conclusion While promising, more clinical validation and standardization are required for general implementation. Bangladesh Journal of Medical Science Vol. 25. Supplementary Issue 2026, Page : S18-S25
- 6 January 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- p. S18-S25
Open AccessAutomation and Robotics in Biosensing for Early Diagnosis and Monitoring of Peri-Implantitis – A Systematic Review.
Background Peri-implantitis is a progressive inflammatory illness that affects implant longevity. Early detection and continuous monitoring are crucial for efficient management. Recent breakthroughs in biosensing, automation, and robotics offer exciting prospects. The purpose of this systematic review is to assess the effectiveness of automation and robotic-assisted biosensing technologies in the early detection and real-time monitoring of peri-implantitis. Methods A complete search of PubMed, Scopus, Cochrane Library, IEEE Xplore, and Web of Science (2013- 2024) was carried out. Studies that used biosensors with automated or robotic systems to diagnose periimplantitis were considered. Methodological quality was evaluated using the PRISMA and ROBIS methods. Results 34 out of 562 articles met the requirements. Biosensing platforms (optical, electrochemical, piezoelectric) with AI integration demonstrated great sensitivity (80-95%) and specificity (85-98%) in detecting early biomarkers such as IL-1β, TNF-α, and MMPs. Robotic systems improved reproducibility and patient comfort. Conclusion While promising, more clinical validation and standardization are required for general implementation. Bangladesh Journal of Medical Science Vol. 25. Supplementary Issue 2026, Page : S18-S25
- Open Access
- 6 January 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- p. S159-S169
Transforming Osteoporosis Detection: Leveraging Vision Transformer using Radiographic Analysis of Mandibular Indices
Background Osteoporosis is a prevalent bone disease characterized by decreased bone density and structural deterioration, leading to increased fracture risk. Osteoporosis affects 200 million people globally, with one in three women and one in five men over 50 experiencing fractures. Early detection and intervention are crucial for reducing morbidity and mortality. Dental panoramic radiographs (DPRs) can be valuable in identifying osteoporosis by analyzing mandibular indices such as the Mental Index, Panoramic Mandibular Index, Gonial Index, Antegonial Index, and Antegonial Depth. These indices reflect specific anatomical features of the mandible that may correlate with bone density changes indicative of osteoporosis. This study introduces a novel approach to osteoporosis detection using Vision Transformer architecture, focusing on long-range dependencies and complex spatial relationships in medical images, aiming for early clinical application. Methods The study will include 600 digital panoramic radiographs from female patients aged 20-30, 30-40, 40-50, 50- 60, 60-70, and above 70 years, for routine dental checkups and examinations. The data will be saved in DICOM format and morphometric measurements will be performed by two oral radiologists. Quantitative indices such as the Mental Index (MI), Panoramic Mandibular Index (PMI), Gonial Index (G.I.), Antegonial Index (A.I.), and Antegonial Depth (A.D.) will be measured. The initial phase of the methodology involves meticulous acquisition and processing of digital panoramic radiographs, which were divided into six age groups. Each radiograph undergoes comprehensive quality assessment, evaluating technical parameters including brightness, contrast, and positioning accuracy. The preprocessing pipeline uses a multi-stage approach, including histogram equalization, Gaussian filtering, CLAHE, and unsharp masking techniques, to enhance contrast and reduce noise. The annotation and the labeling process uses a rigorous multi-reader approach to ensure data quality and reliability, providing a structured summary of key indices and clinical observations and subjected to transformers architecture. Results The Vision Transformer (ViT) model is highly accurate for osteoporosis detection, identifying 96.5% of cases. However, its lower sensitivity raises concerns about its effectiveness. DenseNet-169 and EfficientNet-B4 models are reliable options, with DenseNet-169 promoting feature reuse and EfficientNet-B4 balancing computational efficiency and performance. ResNet-152 needs improvement for accurate patient identification. The “ViT (Best Tuned)” model is the superior choice for osteoporosis detection in dental panoramic radiographs. Conclusion The study explores transformer models for osteoporosis detection using dental panoramic radiographs, highlighting the potential of A.I. in early diagnosis and timely intervention. Future research should focus on creating diverse datasets and integrating multi-modal data like medical history, genetic predispositions, and imaging techniques for better accuracy. This could enhance predictive capability and make machine learning a crucial component of proactive osteoporosis management and patient care. Bangladesh Journal of Medical Science Vol. 25. Supplementary Issue 2026, Page : S159-S169
- 6 January 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- p. S159-S169
Open AccessTransforming Osteoporosis Detection: Leveraging Vision Transformer using Radiographic Analysis of Mandibular Indices
Background Osteoporosis is a prevalent bone disease characterized by decreased bone density and structural deterioration, leading to increased fracture risk. Osteoporosis affects 200 million people globally, with one in three women and one in five men over 50 experiencing fractures. Early detection and intervention are crucial for reducing morbidity and mortality. Dental panoramic radiographs (DPRs) can be valuable in identifying osteoporosis by analyzing mandibular indices such as the Mental Index, Panoramic Mandibular Index, Gonial Index, Antegonial Index, and Antegonial Depth. These indices reflect specific anatomical features of the mandible that may correlate with bone density changes indicative of osteoporosis. This study introduces a novel approach to osteoporosis detection using Vision Transformer architecture, focusing on long-range dependencies and complex spatial relationships in medical images, aiming for early clinical application. Methods The study will include 600 digital panoramic radiographs from female patients aged 20-30, 30-40, 40-50, 50- 60, 60-70, and above 70 years, for routine dental checkups and examinations. The data will be saved in DICOM format and morphometric measurements will be performed by two oral radiologists. Quantitative indices such as the Mental Index (MI), Panoramic Mandibular Index (PMI), Gonial Index (G.I.), Antegonial Index (A.I.), and Antegonial Depth (A.D.) will be measured. The initial phase of the methodology involves meticulous acquisition and processing of digital panoramic radiographs, which were divided into six age groups. Each radiograph undergoes comprehensive quality assessment, evaluating technical parameters including brightness, contrast, and positioning accuracy. The preprocessing pipeline uses a multi-stage approach, including histogram equalization, Gaussian filtering, CLAHE, and unsharp masking techniques, to enhance contrast and reduce noise. The annotation and the labeling process uses a rigorous multi-reader approach to ensure data quality and reliability, providing a structured summary of key indices and clinical observations and subjected to transformers architecture. Results The Vision Transformer (ViT) model is highly accurate for osteoporosis detection, identifying 96.5% of cases. However, its lower sensitivity raises concerns about its effectiveness. DenseNet-169 and EfficientNet-B4 models are reliable options, with DenseNet-169 promoting feature reuse and EfficientNet-B4 balancing computational efficiency and performance. ResNet-152 needs improvement for accurate patient identification. The “ViT (Best Tuned)” model is the superior choice for osteoporosis detection in dental panoramic radiographs. Conclusion The study explores transformer models for osteoporosis detection using dental panoramic radiographs, highlighting the potential of A.I. in early diagnosis and timely intervention. Future research should focus on creating diverse datasets and integrating multi-modal data like medical history, genetic predispositions, and imaging techniques for better accuracy. This could enhance predictive capability and make machine learning a crucial component of proactive osteoporosis management and patient care. Bangladesh Journal of Medical Science Vol. 25. Supplementary Issue 2026, Page : S159-S169
- Top Cited PapersOpen Access
- 8 April 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (4) , 546
Regenerative Strategies in Dentistry: Harnessing Stem Cells, Biomaterials and Bioactive Materials for Tissue Repair
Advanced bioengineering, popularly known as regenerative dentistry, has emerged and is steadily developing with the aim of replacement of lost or injured tissues in the mouth using stem cells and other biomaterials. Conventional therapies for reparative dentistry, for instance fillings or crowns, mainly entail the replenishment of affected tissues without much concern given to the regeneration of tissues. However, these methods do not enable the natural function and aesthetics of the teeth to be maintained in the long term. There are several regenerative strategies that offer the potential to address these limitations to the extent of biologically restoring the function of teeth and their components, like pulp, dentin, bone, and periodontal tissues. Hence, stem cells, especially dental tissue derived stem cells, such as dental pulp stem cells, periodontal ligament stem cells, or apical papilla stem cells, are quite promising in this regard. These stem cells have the potentiality of generating precise dental cell lineages and thus are vital for tissue healing and renewal. Further, hydrogels, growth factors, and synthetic scaffolds help in supporting the stem cells for growth, proliferation, and differentiation into functional tissues. This review aims at describing the process of stem cell-based tissue repair biomaterials in dental regeneration, and also looks into the practice and prospects of regenerative dentistry, analysing several case reports and clinical investigations that demonstrate the efficacy and limitations of the technique. Nonetheless, the tremendous potential for regenerative dentistry is a reality that is currently challenged by biological and technical constraints, such as scarcity of stem cell sources, inadequate vascularization, and the integration of the materials used in the procedure. As we move forward, the prospects for regenerative dentistry are in subsequent developments of stem cell technology, biomaterial optimization, and individualized treatment methods, which might become increasingly integrated in dental practices globally. However, there are regulatory, ethical and economic issues that may pose a hurdle in the further advancement of this discipline.
- 8 April 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (4) , 546
Top Cited PapersOpen AccessRegenerative Strategies in Dentistry: Harnessing Stem Cells, Biomaterials and Bioactive Materials for Tissue Repair
Advanced bioengineering, popularly known as regenerative dentistry, has emerged and is steadily developing with the aim of replacement of lost or injured tissues in the mouth using stem cells and other biomaterials. Conventional therapies for reparative dentistry, for instance fillings or crowns, mainly entail the replenishment of affected tissues without much concern given to the regeneration of tissues. However, these methods do not enable the natural function and aesthetics of the teeth to be maintained in the long term. There are several regenerative strategies that offer the potential to address these limitations to the extent of biologically restoring the function of teeth and their components, like pulp, dentin, bone, and periodontal tissues. Hence, stem cells, especially dental tissue derived stem cells, such as dental pulp stem cells, periodontal ligament stem cells, or apical papilla stem cells, are quite promising in this regard. These stem cells have the potentiality of generating precise dental cell lineages and thus are vital for tissue healing and renewal. Further, hydrogels, growth factors, and synthetic scaffolds help in supporting the stem cells for growth, proliferation, and differentiation into functional tissues. This review aims at describing the process of stem cell-based tissue repair biomaterials in dental regeneration, and also looks into the practice and prospects of regenerative dentistry, analysing several case reports and clinical investigations that demonstrate the efficacy and limitations of the technique. Nonetheless, the tremendous potential for regenerative dentistry is a reality that is currently challenged by biological and technical constraints, such as scarcity of stem cell sources, inadequate vascularization, and the integration of the materials used in the procedure. As we move forward, the prospects for regenerative dentistry are in subsequent developments of stem cell technology, biomaterial optimization, and individualized treatment methods, which might become increasingly integrated in dental practices globally. However, there are regulatory, ethical and economic issues that may pose a hurdle in the further advancement of this discipline.
- Open Access
- 18 February 2025
- Published by Uphills Publishers LLC in South Eastern European Journal of Public Health
- p. 896-910
Diagnostic Accuracy of Artificial Intelligence- Based Models in Periodontitis: A Systematic Review Meta-Analysis
Introduction: Periodontitis is an irreversible disease caused by host-microbe interactions leading to the destruction of tooth-supporting structures. Its complex aetiology makes early diagnosis, staging, and treatment planning challenging but crucial to prevent disease progression. Artificial intelligence (AI) models, particularly Convolutional Neural Networks (CNNs), analyze complex variables, identify patterns, and make accurate predictions. Their use in periodontitis diagnosis can enhance diagnostic accuracy, reduce human error, and provide consistent results. Objectives: This review evaluates the current landscape of AI applications in diagnosing periodontitis, with a focus on CNN-based models used directly or through proxy indicators. Methods: A systematic literature search was conducted in PubMed, Web of Science, CINAHL, Embase, Cochrane Library, and ClinicalTrials.gov up to December 2019. Included studies assessed the diagnostic accuracy of AI models for periodontitis using cross-sectional, case-control, or cohort designs. Aggressive periodontitis cases were excluded. Risk of bias was assessed using the PROBAST tool, and results are presented as a narrative synthesis. Results: AI models, particularly CNNs, demonstrated high diagnostic accuracy for periodontal bone loss using radiographic evidence, often surpassing expert performance. Models like DenseNet and U-Net excelled in segmentation and classification. Challenges included poor image quality, imbalanced datasets, and reliance on proxy indicators, highlighting the need for multivariable approaches. Discussion: AI shows promise in standardizing and scaling periodontitis diagnosis, addressing manpower shortages, and improving outcomes. However, future research should focus on integrating multivariable diagnostic approaches and refining model interpretability for clinical applicability.
- 18 February 2025
- Published by Uphills Publishers LLC in South Eastern European Journal of Public Health
- p. 896-910
Open AccessDiagnostic Accuracy of Artificial Intelligence- Based Models in Periodontitis: A Systematic Review Meta-Analysis
Introduction: Periodontitis is an irreversible disease caused by host-microbe interactions leading to the destruction of tooth-supporting structures. Its complex aetiology makes early diagnosis, staging, and treatment planning challenging but crucial to prevent disease progression. Artificial intelligence (AI) models, particularly Convolutional Neural Networks (CNNs), analyze complex variables, identify patterns, and make accurate predictions. Their use in periodontitis diagnosis can enhance diagnostic accuracy, reduce human error, and provide consistent results. Objectives: This review evaluates the current landscape of AI applications in diagnosing periodontitis, with a focus on CNN-based models used directly or through proxy indicators. Methods: A systematic literature search was conducted in PubMed, Web of Science, CINAHL, Embase, Cochrane Library, and ClinicalTrials.gov up to December 2019. Included studies assessed the diagnostic accuracy of AI models for periodontitis using cross-sectional, case-control, or cohort designs. Aggressive periodontitis cases were excluded. Risk of bias was assessed using the PROBAST tool, and results are presented as a narrative synthesis. Results: AI models, particularly CNNs, demonstrated high diagnostic accuracy for periodontal bone loss using radiographic evidence, often surpassing expert performance. Models like DenseNet and U-Net excelled in segmentation and classification. Challenges included poor image quality, imbalanced datasets, and reliance on proxy indicators, highlighting the need for multivariable approaches. Discussion: AI shows promise in standardizing and scaling periodontitis diagnosis, addressing manpower shortages, and improving outcomes. However, future research should focus on integrating multivariable diagnostic approaches and refining model interpretability for clinical applicability.
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 16 (Suppl 5) , S4242-S4244
Smoking and its Role in Oral Cancer
Oral cancer remains a significant public health concern globally, with smoking identified as a primary risk factor. This abstract reviews the role of smoking in the etiology of oral cancer, emphasizing its contribution to carcinogenesis through the induction of genetic mutations, oxidative stress, and inflammation. Tobacco smoke contains carcinogenic compounds such as polycyclic aromatic hydrocarbons, nitrosamines, and heavy metals, which are implicated in the transformation of oral mucosal cells. Epidemiological studies consistently demonstrate a dose–response relationship between smoking intensity and oral cancer risk. Despite advances in prevention and treatment, smoking cessation remains a critical component in reducing oral cancer incidence. This review underscores the importance of public health initiatives and targeted interventions aimed at mitigating smoking-related oral cancer risk.
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 16 (Suppl 5) , S4242-S4244
Open AccessSmoking and its Role in Oral Cancer
Oral cancer remains a significant public health concern globally, with smoking identified as a primary risk factor. This abstract reviews the role of smoking in the etiology of oral cancer, emphasizing its contribution to carcinogenesis through the induction of genetic mutations, oxidative stress, and inflammation. Tobacco smoke contains carcinogenic compounds such as polycyclic aromatic hydrocarbons, nitrosamines, and heavy metals, which are implicated in the transformation of oral mucosal cells. Epidemiological studies consistently demonstrate a dose–response relationship between smoking intensity and oral cancer risk. Despite advances in prevention and treatment, smoking cessation remains a critical component in reducing oral cancer incidence. This review underscores the importance of public health initiatives and targeted interventions aimed at mitigating smoking-related oral cancer risk.
- Open Access
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 16 (Suppl 5) , S4245-S4247
The Crucial Role of Smoking Cessation in Preventing Oral Cancer
Oral cancer remains a significant public health concern globally, with smoking being a primary risk factor. Smoking cessation has been identified as a crucial intervention in reducing the incidence of oral cancer. This abstract reviews the impact of smoking cessation on oral cancer prevention, emphasizing the benefits of quitting smoking in decreasing the risk of developing oral malignancies. Evidence suggests that smoking cessation not only reduces the immediate risk of oral cancer but also contributes to long-term health improvements. The mechanisms through which smoking cessation exerts its protective effects, including the reduction of carcinogenic exposure and enhancement of oral mucosal health, are discussed. Public health strategies and interventions aimed at promoting smoking cessation are also highlighted as essential components in oral cancer prevention efforts.
- 1 December 2024
- Published by Wolters Kluwer Health in Journal of Pharmacy and Bioallied Sciences
- Vol. 16 (Suppl 5) , S4245-S4247
Open AccessThe Crucial Role of Smoking Cessation in Preventing Oral Cancer
Oral cancer remains a significant public health concern globally, with smoking being a primary risk factor. Smoking cessation has been identified as a crucial intervention in reducing the incidence of oral cancer. This abstract reviews the impact of smoking cessation on oral cancer prevention, emphasizing the benefits of quitting smoking in decreasing the risk of developing oral malignancies. Evidence suggests that smoking cessation not only reduces the immediate risk of oral cancer but also contributes to long-term health improvements. The mechanisms through which smoking cessation exerts its protective effects, including the reduction of carcinogenic exposure and enhancement of oral mucosal health, are discussed. Public health strategies and interventions aimed at promoting smoking cessation are also highlighted as essential components in oral cancer prevention efforts.
- Open Access
Advancements in the Synthesis and Functionalization of Zinc Oxide-Based Nanomaterials for Enhanced Oral Cancer Therapy
The fabrication of zinc oxide-based nanomaterials (including natural and synthetic polymers like sulfated polysaccharide, chitosan, and polymethyl methacrylate) has potential to improve oral cancer treatment strategies. This comprehensive review explores the diverse synthesis methods employed to fabricate zinc oxide nanomaterials tailored for oral cancer applications. Several synthesis processes, particularly sol–gel, hydrothermal, and chemical vapor deposition approaches, are thoroughly studied, highlighting their advantages and limitations. The review also examines how synthesis parameters, such as precursor selection, the reaction temperature, and growth conditions, influence both the physicochemical attributes and biological efficacy of the resulting nanomaterials. Furthermore, recent advancements in surface functionalization and modification strategies targeted at improving the targeting specificity and pharmaceutical effectiveness of zinc oxide-based nanomaterials in oral cancer therapy are elucidated. Additionally, the review provides insights into the existing issues and prospective views in the field, emphasizing the need for further research to optimize synthesis methodologies and elucidate the mechanisms underlying the efficacy of zinc oxide-based nanoparticles in oral cancer therapy.
Open AccessAdvancements in the Synthesis and Functionalization of Zinc Oxide-Based Nanomaterials for Enhanced Oral Cancer Therapy
The fabrication of zinc oxide-based nanomaterials (including natural and synthetic polymers like sulfated polysaccharide, chitosan, and polymethyl methacrylate) has potential to improve oral cancer treatment strategies. This comprehensive review explores the diverse synthesis methods employed to fabricate zinc oxide nanomaterials tailored for oral cancer applications. Several synthesis processes, particularly sol–gel, hydrothermal, and chemical vapor deposition approaches, are thoroughly studied, highlighting their advantages and limitations. The review also examines how synthesis parameters, such as precursor selection, the reaction temperature, and growth conditions, influence both the physicochemical attributes and biological efficacy of the resulting nanomaterials. Furthermore, recent advancements in surface functionalization and modification strategies targeted at improving the targeting specificity and pharmaceutical effectiveness of zinc oxide-based nanomaterials in oral cancer therapy are elucidated. Additionally, the review provides insights into the existing issues and prospective views in the field, emphasizing the need for further research to optimize synthesis methodologies and elucidate the mechanisms underlying the efficacy of zinc oxide-based nanoparticles in oral cancer therapy.
- Open Access
Molecular and Therapeutic Roles of Non-Coding RNAs in Oral Cancer—A Review
Oral cancer (OC) is among the most common malignancies in the world. Despite advances in therapy, the worst-case scenario for OC remains metastasis, with a 50% survival rate. Therefore, it is critical to comprehend the pathophysiology of the condition and to create diagnostic and treatment plans for OC. The development of high-throughput genome sequencing has revealed that over 90% of the human genome encodes non-coding transcripts, or transcripts that do not code for any proteins. This paper describes the function of these different kinds of non-coding RNAs (ncRNAs) in OC as well as their intriguing therapeutic potential. The onset and development of OC, as well as treatment resistance, are linked to dysregulated ncRNA expression. These ncRNAs’ potentially significant roles in diagnosis and prognosis have been suggested by their differing expression in blood or saliva. We have outlined every promising feature of ncRNAs in the treatment of OC in this study.
Open AccessMolecular and Therapeutic Roles of Non-Coding RNAs in Oral Cancer—A Review
Oral cancer (OC) is among the most common malignancies in the world. Despite advances in therapy, the worst-case scenario for OC remains metastasis, with a 50% survival rate. Therefore, it is critical to comprehend the pathophysiology of the condition and to create diagnostic and treatment plans for OC. The development of high-throughput genome sequencing has revealed that over 90% of the human genome encodes non-coding transcripts, or transcripts that do not code for any proteins. This paper describes the function of these different kinds of non-coding RNAs (ncRNAs) in OC as well as their intriguing therapeutic potential. The onset and development of OC, as well as treatment resistance, are linked to dysregulated ncRNA expression. These ncRNAs’ potentially significant roles in diagnosis and prognosis have been suggested by their differing expression in blood or saliva. We have outlined every promising feature of ncRNAs in the treatment of OC in this study.
- 5 May 2024
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 23 (4) , 935-952
Deciphering Annona’s Anticancer Potential: Comparative Analysis of Crude Extract Versus Nanoformulation on SCC-25 Oral Cancer Cells Through cell Viability, Apoptosis, Cell Cycle, ROS, and MMP Analysis
Introduction Annona muricata contains acetogenins, which have shown promising anticancer activity against various cell lines. This study aims to evaluate and compare the anticancer activity of the crude extract of Annona muricata and its nano formulation on Squamous Cell Carcinoma—25 (SCC-25) oral cancer cell lines. Methods The crude extract of Annona muricata was prepared using standard extraction techniques, while its nano formulation was synthesized through nanoparticle fabrication methods. Authenticated SCC-25 cell lines were obtained from ATCC and cultured and treated with varying concentrations of both the crude extract and nano formulation. Cell viability assays, apoptosis assays, Cell Cycle assay, ROS, and MMP analysis techniques were employed to assess the anticancer activity and mechanism of action. Results In the MTT assay, the Annona formulation treated cells exhibited lower IC50 values compared to the crude extract treated SCC-25 cell lines. In the cell cycle assay, the Annona crude extract induced higher cell cycle arrest in the G1 phase in SCC-25 cell lines compared to the control. The nano formulation of Annona demonstrated significantly higher cell cycle arrest in G1 phase compared to both the control and the Annona crude extract-treated SCC-25 cell lines. The crude extract showed less apoptotic activity in apoptosis assay when compared to control, whereas the Annona formulation exhibited higher late apoptosis compared to the control, indicating the potential anticancer properties of Annona. The mean fluorescent intensity test of SCC-25 oral cancer cells treated with Annona crude extract and Annona formulation showed a significant loss of Mitochondrial membrane potential compared to the control. The percentage of MMP was lower in Annona-treated cells, while the Annona formulation treated cells showed similar results to the control. The mean fluorescent intensity of ROS in SCC-25 oral cancer cells treated with Annona crude extract and Annona formulation showed significantly lower Reactive oxygen species production compared to the control. The percentage of ROS was lower in Annona treated cells compared to the formulation, but the Annona formulation-treated cells showed lower values than the control. Conclusion In conclusion, both the crude extract and nano formulation of Annona muricata possess potent anticancer activity against SCC-25 oral cancer cell lines. However, the nano formulation exhibited superior efficacy, suggesting its potential for further development as a therapeutic agent for oral cancer treatment.
- 5 May 2024
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 23 (4) , 935-952
Deciphering Annona’s Anticancer Potential: Comparative Analysis of Crude Extract Versus Nanoformulation on SCC-25 Oral Cancer Cells Through cell Viability, Apoptosis, Cell Cycle, ROS, and MMP Analysis
Introduction Annona muricata contains acetogenins, which have shown promising anticancer activity against various cell lines. This study aims to evaluate and compare the anticancer activity of the crude extract of Annona muricata and its nano formulation on Squamous Cell Carcinoma—25 (SCC-25) oral cancer cell lines. Methods The crude extract of Annona muricata was prepared using standard extraction techniques, while its nano formulation was synthesized through nanoparticle fabrication methods. Authenticated SCC-25 cell lines were obtained from ATCC and cultured and treated with varying concentrations of both the crude extract and nano formulation. Cell viability assays, apoptosis assays, Cell Cycle assay, ROS, and MMP analysis techniques were employed to assess the anticancer activity and mechanism of action. Results In the MTT assay, the Annona formulation treated cells exhibited lower IC50 values compared to the crude extract treated SCC-25 cell lines. In the cell cycle assay, the Annona crude extract induced higher cell cycle arrest in the G1 phase in SCC-25 cell lines compared to the control. The nano formulation of Annona demonstrated significantly higher cell cycle arrest in G1 phase compared to both the control and the Annona crude extract-treated SCC-25 cell lines. The crude extract showed less apoptotic activity in apoptosis assay when compared to control, whereas the Annona formulation exhibited higher late apoptosis compared to the control, indicating the potential anticancer properties of Annona. The mean fluorescent intensity test of SCC-25 oral cancer cells treated with Annona crude extract and Annona formulation showed a significant loss of Mitochondrial membrane potential compared to the control. The percentage of MMP was lower in Annona-treated cells, while the Annona formulation treated cells showed similar results to the control. The mean fluorescent intensity of ROS in SCC-25 oral cancer cells treated with Annona crude extract and Annona formulation showed significantly lower Reactive oxygen species production compared to the control. The percentage of ROS was lower in Annona treated cells compared to the formulation, but the Annona formulation-treated cells showed lower values than the control. Conclusion In conclusion, both the crude extract and nano formulation of Annona muricata possess potent anticancer activity against SCC-25 oral cancer cell lines. However, the nano formulation exhibited superior efficacy, suggesting its potential for further development as a therapeutic agent for oral cancer treatment.
- Open Access
- 1 January 2024
- Published by Wiley in Advances in Public Health
- Vol. 2024 (1)
Role of Artificial Intelligence in Oral Cancer
Oral malignancy, notably oral squamous cell carcinoma (OSCC), stands as a formidable global health issue, characterized by disparate prevalence among demographics and geographic regions. Traditional diagnostic modalities, reliant on biopsy and histopathological methods, they all often exhibit constraints in expeditiousness and subjectivity, thus an alternative methodologies are needed for fostering early detection and personalized therapeutic strategies. Artificial intelligence (AI) emerges as a forefront avenue in oral cancer (OC) therapeutics, engaged in providing solutions for diagnostic augmentation, treatment optimization, and prognostic delineation. Machine learning paradigms, encompassing supervised and unsupervised learning, afford meticulous classification and pattern identification from multifarious clinical and histopathological datasets. Deep learning architectures, exemplified by convolutional neural networks (CNNs), automatize lesion detection, and characterization from medical imagery, thereby expediting diagnostic efficacy. Predictive analytics methodologies combine multifaceted patient data to access risk and prognosticate disease trajectory, thereby facilitating bespoke treatment schema. Expert systems harness medical knowledge and patient‐centric intelligence to furnish decision support for clinicians in treatment modality selection and disease monitoring. Robotic and automated systems contribute to surgical precision and procedural streamlining, ultimately fostering enhanced patient outcomes. Despite these advancements, challenges remain persists necessitating continued interdisciplinary collaboration and research efforts. This review explores about burgeoning role of AI in OC therapeutics, elucidating extant applications, challenges, and future trajectories for research and clinical adoption in oral oncology.
- 1 January 2024
- Published by Wiley in Advances in Public Health
- Vol. 2024 (1)
Open AccessRole of Artificial Intelligence in Oral Cancer
Oral malignancy, notably oral squamous cell carcinoma (OSCC), stands as a formidable global health issue, characterized by disparate prevalence among demographics and geographic regions. Traditional diagnostic modalities, reliant on biopsy and histopathological methods, they all often exhibit constraints in expeditiousness and subjectivity, thus an alternative methodologies are needed for fostering early detection and personalized therapeutic strategies. Artificial intelligence (AI) emerges as a forefront avenue in oral cancer (OC) therapeutics, engaged in providing solutions for diagnostic augmentation, treatment optimization, and prognostic delineation. Machine learning paradigms, encompassing supervised and unsupervised learning, afford meticulous classification and pattern identification from multifarious clinical and histopathological datasets. Deep learning architectures, exemplified by convolutional neural networks (CNNs), automatize lesion detection, and characterization from medical imagery, thereby expediting diagnostic efficacy. Predictive analytics methodologies combine multifaceted patient data to access risk and prognosticate disease trajectory, thereby facilitating bespoke treatment schema. Expert systems harness medical knowledge and patient‐centric intelligence to furnish decision support for clinicians in treatment modality selection and disease monitoring. Robotic and automated systems contribute to surgical precision and procedural streamlining, ultimately fostering enhanced patient outcomes. Despite these advancements, challenges remain persists necessitating continued interdisciplinary collaboration and research efforts. This review explores about burgeoning role of AI in OC therapeutics, elucidating extant applications, challenges, and future trajectories for research and clinical adoption in oral oncology.